Internal Medicine, Hematology & Oncology · Victorville, CA
NPI
1386841963
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
12998 Hesperia Rd, Suite 204
Victorville, CA, 92395
Phone (760) 780-4960
Medicare paid, 2024
$1.6M
105,245 services
Medicare patients, 2024
569
Average age 74
Drug cost, 2024
$7.7M
2,509 prescriptions
Company payments, 2025
$4,744
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vir K Nanda was code J0185 (injection, aprepitant, 1 mg), 7,540 times for 19 patients. In total Vir K Nanda billed 105,245 services in 107 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-05-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0185 Injection, aprepitant, 1 mg | Office | 7,540 | 19 | $1.35 | $10K |
| J0897 Injection, denosumab, 1 mg | Office | 6,840 | 35 | $20.58 | $141K |
| J1627 Injection, granisetron, extended-release, 0.1 mg | Office | 4,000 | 14 | $4.40 | $18K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,600 | 14 | $16.06 | $26K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,228 | 28 | $0.09 | $110 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 720 | 16 | $0.73 | $525 |
| 99213 Office E&M - Established | Office | 509 | 317 | $62.28 | $32K |
| Q5127 Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg | Office | 420 | 12 | $257.56 | $108K |
| 99214 Office E&M - Established | Office | 334 | 225 | $98.88 | $33K |
| 96372 Injection Administration | Office | 319 | 75 | $11.23 | $3,582 |
| 96367 Intravenous Infusion, Hydration | Office | 174 | 32 | $23.08 | $4,016 |
| 96413 Chemotherapy Administration | Office | 155 | 34 | $104.86 | $16K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 135 | 19 | $4.67 | $630 |
| J3490 Unclassified drugs | Office | 117 | 27 | $0.59 | $68.86 |
| 96415 Chemotherapy Administration | Office | 113 | 29 | $22.25 | $2,514 |
By year: 2022 $1.8M for 187,498 services; 2023 $1.7M for 117,435 services; 2024 $1.6M for 105,245 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vir K Nanda prescribed most often to Medicare patients was Anastrozole, with 403 prescriptions and refills. In total Vir K Nanda wrote 2,509 Medicare prescriptions that cost $7.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 403 | 842 | 97 | $4,952 |
| Letrozole Generic | 284 | 549 | 79 | $5,547 |
| Alendronate Sodium Generic | 120 | 206 | 24 | $587 |
| Hydroxyurea Generic | 118 | 237 | 31 | $3,630 |
| Eliquis Apixaban | 96 | 133 | 20 | $72K |
| Orgovyx Relugolix | 91 | 93 | 12 | $244K |
| Ondansetron Odt Ondansetron | 86 | 88 | 45 | $1,583 |
| Jakafi Ruxolitinib Phosphate | 79 | 80 | Under 11 | $1.3M |
| Kisqali Ribociclib Succinate | 72 | 72 | Under 11 | $1.1M |
| Levothyroxine Sodium Generic | 71 | 129 | 17 | $574 |
| Xtandi Enzalutamide | 63 | 63 | Under 11 | $839K |
| Revlimid Lenalidomide | 61 | 61 | 12 | $1.1M |
| Prochlorperazine Maleate Generic | 55 | 55 | 32 | $828 |
| Tamoxifen Citrate Generic | 52 | 94 | Under 11 | $836 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 48 | 48 | 20 | $1,558 |
Brand drugs: 681 claims; generic drugs: 1,828 claims; opioid claims: 93.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vir K Nanda $4,744 ($4,744 in general payments such as food, travel and fees) from 10 companies. The largest payer was B. Braun Medical Inc. with $3,388.
| Company | Payments | Amount |
|---|---|---|
| B. Braun Medical Inc. | 1 | $3,388 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $1,057 |
| Astellas Pharma US Inc 4503.T | 5 | $98.91 |
| Eisai Inc. 4523.T | 2 | $46.46 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $38.34 |
| Abbvie Inc. ABBV | 1 | $32.29 |
| Karyopharm Therapeutics Inc. KPTI | 1 | $24.17 |
| Array Biopharma Inc PFE | 1 | $23.53 |
| Celgene Corporation BMY | 1 | $18.49 |
| Myriad Genetic Laboratories, Inc. MYGN | 1 | $16.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.